Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
304
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Samsung Biologics
•
25 May 2018 10:35
FSC Chairman Speaks on Decision Framework
An article in the 24 May issue of BusinessKorea (link below) reports on a talk given by Financial Services Commission (FSC) Chairman Choi...
Kemp Dolliver, CFA
291 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 May 2018 22:45
The Week That Was in North Asia @Smartkarma: Do Donkis Rohm the North Korean Shires?
Firstly, apologies for the terrible string of puns, but the image just sticks in our head.Kospi rose 0.66% for the week while Topix rose 1.32%,...
Mio Kato
Follow
205 Views
Share
bullish
•
Samsung Biologics
•
13 May 2018 00:21
Last Week in Event SPACE: Samsung Biologics, Shire, Lotte, Mitula, JSW, Nisshinbo
Last Week in Event SPACE ... In what is probably the secondmost interesting arb in the world, the attractive trade may simply be to go long LIFULL...
David Blennerhassett
Follow
245 Views
Share
bullish
•
Samsung Biologics
•
10 May 2018 04:38
FSS Vs. Samsung BioLogics - Latest Situation Update
Below is how the Samsung BioLogics accounting fraud case will be reviewed and concluded by the FSC. The FSS (Financial Supervisory Service) tables...
Sanghyun Park
Follow
196 Views
Share
bullish
•
Genoray Co Ltd
•
08 May 2018 12:13
Genoray IPO Preview (Part 2) - Valuation Analysis
We are positive on the Genoray IPO. Our one year price target of the company is 25,944 won, which would represent nearly 27% higher than the high...
Douglas Kim
Follow
218 Views
Share
First
Previous
44
45
46
47
48
49
50
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x